Zu "231277-92-2" wurden 5 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Lapatinib
Artikelnummer: TGM-T0078-100mg
Description: Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity. Lapatinib has antitumor activity and can be used to treat advanced or metastatic breast cancer with HER2 overexpression. Target: Autophagy, EGFR, Ferroptosis. Smiles:...
| Schlagworte: | GW572016, GSK572016 |
| CAS | 231277-92-2 |
| MW: | 581.06 D |
ab 30,00 €
Lapatinib
Artikelnummer: Cay11493-10
Lapatinib is a dual inhibitor of the EGF receptor (EGFR) and ErbB2 (IC50s = 19 and 3 nM, respectively). It inhibits the growth of EGFR-overexpressing A431 skin cancer and ErbB2-overexpressing SK-BR-3 breast cancer cells (IC50s = 0.14 and 0.124 µM, respectively). Lapatinib also inhibits the growth of ErbB2-amplified...
| Schlagworte: | GSK 572016, GW 572016,... |
| Anwendung: | EGFR / HER2 inhibitor |
| CAS | 231277-92-2 |
| MW: | 581.1 D |
ab 78,00 €
Lapatinib free base
Artikelnummer: LKT-L0362.100
Inhibitor of EGFR/HER2 (ErbB2).
| Schlagworte: | GSK572016, GW572016 |
| Anwendung: | EGFR tyrosine kinase inhibitor, ERBB2 tyrosine kinase inhibitor |
| CAS | 231277-92-2 |
| MW: | 581.06 D |
ab 80,00 €
![Lapatinib, Free Base (N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl](https://www.biomol.com/media/image/7a/bd/d9/L1315-51-100_200x200.jpg "Lapatinib, Free Base (N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl")
Lapatinib, Free Base...
Artikelnummer: L1315-51.100
ATP-competitive EGFR & ErbB-2 dual tyrosine kinase inhibitor. Lapatinib is an ATP-competitive epidermal growth factor receptor (EGFR) and HER2/neu (ErbB-2) dual tyrosine kinase inhibitor, with IC(50) values of 10.8 and 9.2nm respectively. It is an orally active drug for treatment of breast cancer and other solid...
| CAS | 231277-92-2 |
| MW: | 581.06 |
214,00 €
Lapatinib
Artikelnummer: SYN-1052-M001
Soluble in DMSO or ethanol. Lapatinib is an ATP-competitive epidermal growth factor receptor (EGFR) and HER2/neu (ErbB-2) dual tyrosine kinase inhibitor, with IC(50) values of 10.8 and 9.2nM respectively. It is an orally active drug for treatment of breast cancer and other solid tumors. Target: EGFR , Kinase...
| Schlagworte: | GW-572016 |
| Anwendung: | EGFR / ErbB2 inhibitor |
| CAS | 231277-92-2 |
| MW: | 581,1 D |
ab 77,00 €
